Article
Metronidazole resistance among clinical isolates belonging to the Bacteroides fragilis group: time to be concerned?
1 Oct 1999
Abstract excerpt
J Antimicrob Chemother 1999; 44: 580–581 Sir, Despite metronidazole (5-nitroimidazole) now being in its fortieth year, this remarkable drug remains extensively and effectively used for the prevention and treatment of anaerobic infections, as well as for the treatment of patients with infections caused by Trichomonas vaginalisand Helicobacter pylori. There is, however, a paucity of data on the incidence of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
